Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Hyperbaric Oxygen Therapy in Children with Brain Injury: A Retrospective Case Series

M. Hajek, O. Jor, J. Tlapak, D. Chmelar

. 2025 ; 22 (3) : 473-481. [pub] 20250101

Language English Country Australia

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc25010373

Introduction and Importance: Some experimental studies on brain injury associated with traumatic brain injury (TBI) and hypoxic-ischaemic encephalopathy (HIE) reveal a positive effect of hyperbaric oxygen therapy (HBOT). However, in clinical medicine, most of the scientific evidence available in the current literature relates only to TBI. Methods: The primary objective is to empirically assess the efficacy of HBOT in mitigating the symptoms of disability associated with brain injury in children, with a view to elucidating its therapeutic potential and clinical benefits. Outcomes: A total of 21 patients have been treated with HBOT. The mean age was 6±4.6 years. There were 12 cases (57%) of TBI, 8 cases (38%) of HIE and 1 case (5%) of ischaemic stroke. The mean initial Glasgow Coma Scale (GCS) at hospital admission immediately after accident was 3.3±0.9. The mean time from injury to HBOT was 5.2 ± 3.8 weeks. The mean number of HBOT exposures was 10±4.3. The mean GCS pre-HBOT was 10.7±3.7 and 12.3±3.4 (p=0.004) after post-HBOT, respectively. The mean Glasgow Outcome Scale (GOS) was 3.3±0.8 pre-HBOT, and 3.9±1.1 (p<0.001) after post-HBOT, respectively. Eighteen cases were included in response to HBOT assessment. Six cases (33%) were evaluated as large clinically significant response (CSR), 7 cases (39%) were evaluated as partial response with minimally important difference (MID). Five cases (28%) were evaluated as non-response. The results showed better response to HBOT in cases of starting HBOT up to 4 weeks (p=0.02) after the injury. There was no serious HBOT-related complication or injury. Conclusion: Results of our study demonstrate both clinical and statistically significant patient response to HBOT. Our data also suggest that the earlier HBOT started after diagnosis up to 4 weeks, the more pronounced patients' response to HBOT was achieved. The provision of HBOT to pediatric patients is feasible in large regional hyperbaric centers.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25010373
003      
CZ-PrNML
005      
20250429135209.0
007      
ta
008      
250415s2025 at f 000 0|eng||
009      
AR
024    7_
$a 10.7150/ijms.102884 $2 doi
035    __
$a (PubMed)39898239
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a at
100    1_
$a Hajek, Michal $u Centre of Hyperbaric Medicine, Ostrava City Hospital, Ostrava, Czech Republic $u Institute of Laboratory Medicine, Institute of Microbiology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic $u Centre for Hyperbaric Medicine of Faculty of Medicine University of Ostrava and Ostrava City Hospital, Ostrava, Czech Republic
245    10
$a Hyperbaric Oxygen Therapy in Children with Brain Injury: A Retrospective Case Series / $c M. Hajek, O. Jor, J. Tlapak, D. Chmelar
520    9_
$a Introduction and Importance: Some experimental studies on brain injury associated with traumatic brain injury (TBI) and hypoxic-ischaemic encephalopathy (HIE) reveal a positive effect of hyperbaric oxygen therapy (HBOT). However, in clinical medicine, most of the scientific evidence available in the current literature relates only to TBI. Methods: The primary objective is to empirically assess the efficacy of HBOT in mitigating the symptoms of disability associated with brain injury in children, with a view to elucidating its therapeutic potential and clinical benefits. Outcomes: A total of 21 patients have been treated with HBOT. The mean age was 6±4.6 years. There were 12 cases (57%) of TBI, 8 cases (38%) of HIE and 1 case (5%) of ischaemic stroke. The mean initial Glasgow Coma Scale (GCS) at hospital admission immediately after accident was 3.3±0.9. The mean time from injury to HBOT was 5.2 ± 3.8 weeks. The mean number of HBOT exposures was 10±4.3. The mean GCS pre-HBOT was 10.7±3.7 and 12.3±3.4 (p=0.004) after post-HBOT, respectively. The mean Glasgow Outcome Scale (GOS) was 3.3±0.8 pre-HBOT, and 3.9±1.1 (p<0.001) after post-HBOT, respectively. Eighteen cases were included in response to HBOT assessment. Six cases (33%) were evaluated as large clinically significant response (CSR), 7 cases (39%) were evaluated as partial response with minimally important difference (MID). Five cases (28%) were evaluated as non-response. The results showed better response to HBOT in cases of starting HBOT up to 4 weeks (p=0.02) after the injury. There was no serious HBOT-related complication or injury. Conclusion: Results of our study demonstrate both clinical and statistically significant patient response to HBOT. Our data also suggest that the earlier HBOT started after diagnosis up to 4 weeks, the more pronounced patients' response to HBOT was achieved. The provision of HBOT to pediatric patients is feasible in large regional hyperbaric centers.
650    _2
$a lidé $7 D006801
650    12
$a hyperbarická oxygenace $x metody $7 D006931
650    _2
$a dítě $7 D002648
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a předškolní dítě $7 D002675
650    _2
$a retrospektivní studie $7 D012189
650    12
$a Glasgowská stupnice kómat $7 D015600
650    _2
$a výsledek terapie $7 D016896
650    _2
$a mladiství $7 D000293
650    12
$a mozková hypoxie a ischemie $x terapie $7 D020925
650    _2
$a traumatické poranění mozku $x terapie $7 D000070642
650    _2
$a poranění mozku $x terapie $7 D001930
650    _2
$a kojenec $7 D007223
650    _2
$a Glasgowská stupnice následků $7 D023261
655    _2
$a časopisecké články $7 D016428
700    1_
$a Jor, Ondrej $u Centre for Hyperbaric Medicine of Faculty of Medicine University of Ostrava and Ostrava City Hospital, Ostrava, Czech Republic $u Department of Anaesthesiology, Resuscitation and Intensive Care Medicine, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic $u Department of Anaesthesiology and Intensive Care Medicine, University Hospital of Ostrava, Ostrava, Czech Republic
700    1_
$a Tlapak, Jakub $u The Institute of Aviation Medicine, Prague, Czech Republic $u Faculty of Biomedical Engineering, Czech Technical University in Prague, Czech Republic
700    1_
$a Chmelar, Dittmar $u Institute of Laboratory Medicine, Institute of Microbiology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic $u Centre for Hyperbaric Medicine of Faculty of Medicine University of Ostrava and Ostrava City Hospital, Ostrava, Czech Republic
773    0_
$w MED00176129 $t International journal of medical sciences $x 1449-1907 $g Roč. 22, č. 3 (2025), s. 473-481
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39898239 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250415 $b ABA008
991    __
$a 20250429135204 $b ABA008
999    __
$a ok $b bmc $g 2311621 $s 1247454
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 22 $c 3 $d 473-481 $e 20250101 $i 1449-1907 $m International journal of medical sciences $n Int J Med Sci $x MED00176129
LZP    __
$a Pubmed-20250415

Find record

Citation metrics

Archiving options